India: Lapses In Bhu Research On Covid-19 Vaccine Covaxin: Bharat Biotech | Wion

India: Lapses in BHU research on Covid-19 vaccine Covaxin: Bharat Biotech | WION

WION

Bharat Biotech releases Covaxin's price ahead of India's phase 3 of vaccination | COVID-19 Vaccine

WION

Study: Covaxin developed by Indian Pharma firm Bharat Biotech neutralizes UK variant | COVID-19

WION

Bharat Biotech's Covaxin Shows Promising Results | Coronavirus Vaccine Update

Bharat Biotech's Covaxin: All You Need To Know About Covid Vaccine | India Today

Coronavirus Vaccine| Bharat Biotech's Top Brass Slams Covaxin Critics| Covid-19 News | Covid Vaccine

The Development of Covaxin

India's first indigenous vaccine 'Covaxin' gets expert panel's nod | Bharat Biotech | World News

WION

Covid vaccine: Bharat Biotech ends deal with Brazil; EU approves Moderna for kids

Hindustan Times

Coronavirus Vaccine | Covaxin Works Against UK Strain, Variant Found in India: Bharat Biotech

NDTV

COVID-19 Vaccine: Who Shouldn't Take Covaxin Shot? Bharat Biotech Explains Amid Concerns

NDTV

Bharat Biotech Seeks Emergency Use Authorisation For Covid Vaccine Covaxin In India

India: Bharat Biotech latest to seek emergency use authorisation | Covaxin | COVID-19 Vaccine

WION

COVID-19 vaccine: Australia recognises Bharat Biotech's Covaxin for travel purposes

The Economic Times

iNCOVACC - India's First Intranasal COVID Vaccine By Bharat Biotech

Coronavirus Update: Animal Trials Of Bharat Biotech COVID-19 vaccine Covaxin Successful

India's apex medical research body is looking to make COVID-19 vaccine available by Aug 15

WION

Is India 1 of 5 Countries Making COVID-19 Vaccine & Bharat Biotech's Covaxin the Best?

Bharat Biotech's Covaxin Shows 78% Efficacy, Claims ICMR Study | Breaking News | India Today

Covid-19 Vaccine: Covaxin Overall 77.8% Effective, Claims Bharat Biotech In Final Phase 3 Data

NDTV